Amaroq Therapeutics

Developer of gene therapies for cancer treatment

placeDunedin, Otago, New Zealand calendar_todayFounded 2021 language amaroqtx.com

Registered entities

Investor mix

5 investors on record; lead investors include Brandon Capital.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon